Forest Laboratories Licenses Novel NMDA Receptor Antagonist from Merz + Co.
06-Jul-2001
Most read news
Topics
MERZ
Forest Laboratories
phase II studies
neuropathic pain
license agreements
Germany
Alzheimer's disease
Organizations
Forest Laboratories
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.